Enhancing RNA 3D Structure Prediction: A Hybrid Approach Combining Expert Knowledge and Computational Tools in CASP16
Proteins: Structure, Function, and Bioinformatics · 2026-01 · 94 (1) · 230-238
DOI: 10.1002/prot.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proteins: Structure, Function, and Bioinformatics, online erschienen am 08.08.2025. Verfasst von Bowen Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou National Laboratory, Guangzhou, China. Hauptthemen laut MEDLINE: Computational Biology, Nucleic Acid Conformation, RNA, Software. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Major Projects of Guangzhou National Laboratory, National Natural Science Foundation of China, Guangdong Science and Technology Department.
Abstract (Originalsprache)
RNA three‐dimensional structures are critical for their roles in gene expression and regulation. However, predicting RNA structures remains challenging due to complex tertiary interactions, ion dependency, molecular flexibility, and the limited availability of known 3D structures. To address these challenges, our team (GuangzhouRNA‐human) employed a hybrid strategy combining computational tools with expert refinement in the CASP16 RNA structure prediction challenge, achieving second place based on the sum Z ‐score. Our approach integrates multiple techniques through modular workflows, including template‐based modeling for targets with homologous templates and ab initio prediction using deep learning tools (e.g., AlphaFold3 and DeepFoldRNA) for novel sequences. Additionally, we incorporate experimental constraints and iterative optimization to enhance prediction accuracy. For targets shorter than 200 nucleotides (nt) with homologous templates, our method demonstrated exceptional performance, achieving 75% of predictions with root‐mean‐square deviations (RMSD) below 5 Å, and all predictions falling under 10 Å. Furthermore, our strategy demonstrated promising results for targets without homologous templates, such as R1209, through comprehensive literature reviews and structural selection. Despite these advances, RNA structure prediction continues to face challenges, particularly in predicting complex topologies like pseudoknots and coaxial stacking. Future improvements in integrating computational tools with expert knowledge are essential to enhance the accuracy and applicability of RNA tertiary structure prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou National Laboratory, Guangzhou, China.
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Bowen Xiao
Förderung
- Major Projects of Guangzhou National Laboratory
- National Natural Science Foundation of China
- Guangdong Science and Technology Department
- National Key R&D Programs of China
Zitieren
APA
Xiao, B., Shi, Y., & Huang, L. (2026). Enhancing RNA 3D Structure Prediction: A Hybrid Approach Combining Expert Knowledge and Computational Tools in CASP16. Proteins: Structure, Function, and Bioinformatics, 94(1), 230-238. https://doi.org/10.1002/prot.70034
Vancouver
Xiao B, Shi Y, Huang L. Enhancing RNA 3D Structure Prediction: A Hybrid Approach Combining Expert Knowledge and Computational Tools in CASP16. Proteins: Structure, Function, and Bioinformatics. 2026;94(1):230-238. doi:10.1002/prot.70034
BibTeX
@article{Xiao2026,
author = {Xiao, Bowen and Shi, Yaohuang and Huang, Lin},
title = {Enhancing RNA 3D Structure Prediction: A Hybrid Approach Combining Expert Knowledge and Computational Tools in CASP16},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2026},
volume = {94},
number = {1},
pages = {230--238},
doi = {10.1002/prot.70034}
}
EUVIMED